Abstract:Activated p53 signaling has important roles, including antiangiogenic, cell cycle arrest, promotion of DNA repair, regulation of cellular metabolism, and promotion of apoptosis. A novel p53‐dependent downstream gene, TRIAP1, inhibits the mitochondria‐dependent apoptotic pathway. This work systematically describes the molecular regulatory mechanism of p53 signaling and suggests that TRIAP1 has potential therapeutic value. Tumor suppressor p53 can transcriptionally activate downstream genes in response to stress, and then regulate the cell cycle, DNA repair, metabolism, angiogenesis, apoptosis, and other biological responses. p53 has seven functional domains and 12 splice isoforms, and different domains and subtypes play different roles. The activation and inactivation of p53 are finely regulated and are associated with phosphorylation/acetylation modification and ubiquitination modification, respectively. Abnormal activation of p53 is closely related to the occurrence and development of cancer. While targeted therapy of the p53 signaling pathway is still in its early stages and only a few drugs or treatments have entered clinical trials, the development of new drugs and ongoing clinical trials are expected to lead to the widespread use of p53 signaling‐targeted therapy in cancer treatment in the future. TRIAP1 is a novel p53 downstream inhibitor of apoptosis. TRIAP1 is the homolog of yeast mitochondrial intermembrane protein MDM35, which can play a tumor‐promoting role by blocking the mitochondria‐dependent apoptosis pathway. This work provides a systematic overview of recent basic research and clinical progress in the p53 signaling pathway and proposes that TRIAP1 is an important therapeutic target downstream of p53 signaling.

Progress in the Studies of Tumor Suppressor hTid1

The Roles and Mechanisms of YTH Domain-Containing Proteins in Cancer Development and Progression.

DNAJA3/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells

Advances on HINT1, a Novel Tumor Suppressor

Structural and functional characterization of tumor suppressors TIG3 and H-REV107.

A review of the mechanism of DDIT4 serve as a mitochondrial related protein in tumor regulation

The development of cancers research based on mitochondrial heat shock protein 90

Progress and Prospects: Roles of P53 in Tumor Development

TIP30 Acts As a Tumor Suppressor in Hepatocarcinogenesis

Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.

TWIST1 and Cancer

Molecular chaperones: Guardians of tumor suppressor stability and function

Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy.

Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies

Biological role and expression of translationally controlled tumor protein (TCTP) in tumorigenesis and development and its potential for targeted tumor therapy

Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer

The Biological Function and the Regulatory Roles of Wild-Type P53-Induced Phosphatase 1 in Immune System

STUB1/CHIP: New insights in cancer and immunity

Targeting HSF1 for cancer treatment: mechanisms and inhibitor development

Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses

TMSG-1 and Its Roles in Tumor Biology